|
1
|
Beiki O, Hall P, Ekbom A and Moradi T:
Breast cancer incidence and case fatality among 4.7 million women
in relation to social and ethnic background: A population-based
cohort study. Breast Cancer Res. 14:R52012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nahta R and Esteva FJ: HER2 therapy:
Molecular mechanisms of trastuzumab resistance. Breast Cancer Res.
8:2152006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan
M, Zhou X, Xia W, Hortobagyi GN, Yu D, et al: Upregulation of CXCR4
is essential for HER2-mediated tumor metastasis. Cancer Cell.
6:459–469. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernandes J, Castilho RO, da Costa MR,
Wagner-Souza K, Coelho Kaplan MA and Gattass CR: Pentacyclic
triterpenes from Chrysobalanaceae species: Cytotoxicity on
multidrug resistant and sensitive leukemia cell lines. Cancer Lett.
190:165–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fernandes J, Weinlich R, Castilho RO,
Kaplan MA, Amarante-Mendes GP and Gattass CR: Pomolic acid triggers
mitochondria-dependent apoptotic cell death in leukemia cell line.
Cancer Lett. 219:49–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vasconcelos FC, Gattass CR, Rumjanek VM
and Maia RC: Pomolic acid-induced apoptosis in cells from patients
with chronic myeloid leukemia exhibiting different drug resistance
profile. Invest New Drugs. 25:525–533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim B, Kim JH and Park B: Pomolic acid
inhibits invasion of breast cancer cells through the suppression of
CXC chemokine receptor type 4 epression. J Cell Biochem.
117:1296–1307. 2016. View Article : Google Scholar
|
|
10
|
Lee MK, Lee KY, Jeon HY, Sung SH and Kim
YC: Antifibrotic activity of triterpenoids from the aerial parts of
Euscaphis japonica on hepatic stellate cells. J Enzyme Inhib Med
Chem. 24:1276–1279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
Yu D and Hung MC: Overexpression of ErbB2
in cancer and ErbB2-targeting strategies. Oncogene. 19:6115–6121.
2000. View Article : Google Scholar
|
|
13
|
Yan YY, Zheng LS, Zhang X, Chen LK, Singh
S, Wang F, Zhang JY, Liang YJ, Dai CL, Gu LQ, et al: Blockade of
Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone
derivative induces proteasomal degradation of Her2/neu. Mol Pharm.
8:1687–1697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marchese A and Benovic JL:
Agonist-promoted ubiquitination of the G protein-coupled receptor
CXCR4 mediates lysosomal sorting. J Biol Chem. 276:45509–45512.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhandari D, Trejo J, Benovic JL and
Marchese A: Arrestin-2 interacts with the ubiquitin-protein
isopeptide ligase atrophin-interacting protein 4 and mediates
endosomal sorting of the chemokine receptor CXCR4. J Biol Chem.
282:36971–36979. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pangburn HA, Ahnen DJ and Rice PL:
Sulindac metabolites induce proteosomal and lysosomal degradation
of the epidermal growth factor receptor. Cancer Prev Res (Phila).
3:560–572. 2010. View Article : Google Scholar
|
|
17
|
Andela VB, Schwarz EM, Puzas JE, O'Keefe
RJ and Rosier RN: Tumor metastasis and the reciprocal regulation of
prometastatic and antimetastatic factors by nuclear factor kappaB.
Cancer Res. 60:6557–6562. 2000.PubMed/NCBI
|
|
18
|
Rivas MA, Tkach M, Beguelin W, Proietti
CJ, Rosemblit C, Charreau EH, Elizalde PV and Schillaci R:
Transactivation of ErbB-2 induced by tumor necrosis factor alpha
promotes NF-kappaB activation and breast cancer cell proliferation.
Breast Cancer Res Treat. 122:111–124. 2010. View Article : Google Scholar
|
|
19
|
Guo G, Wang T, Gao Q, Tamae D, Wong P,
Chen T, Chen WC, Shively JE, Wong JY and Li JJ: Expression of ErbB2
enhances radiation-induced NF-kappaB activation. Oncogene.
23:535–545. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Helbig G, Christopherson KW II,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adeyinka A, Nui Y, Cherlet T, Snell L,
Watson PH and Murphy LC: Activated mitogen-activated protein kinase
expression during human breast tumorigenesis and breast cancer
progression. Clin Cancer Res. 8:1747–1753. 2002.PubMed/NCBI
|
|
22
|
Yu T, Wu Y, Helman JI, Wen Y, Wang C and
Li L: CXCR4 promotes oral squamous cell carcinoma migration and
invasion through inducing expression of MMP-9 and MMP-13 via the
ERK signaling pathway. Mol Cancer Res. 9:161–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khan S, Shukla S, Sinha S, Lakra AD, Bora
HK and Meeran SM: Centchroman suppresses breast cancer metastasis
by reversing epithelial-mesenchymal transition via downregulation
of HER2/ERK1/2/MMP-9 signaling. Int J Biochem Cell Biol. 58:1–16.
2015. View Article : Google Scholar
|
|
24
|
Zhan Y, Zhang H, Li J, Zhang Y, Zhang J
and He L: A novel biphenyl urea derivate inhibits the invasion of
breast cancer through the modulation of CXCR4. J Cell Mol Med.
19:1614–1623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Appert-Collin A, Hubert P, Crémel G and
Bennasroune A: Role of ErbB Receptors in Cancer Cell Migration and
Invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berger MS, Locher GW, Saurer S, Gullick
WJ, Waterfield MD, Groner B and Hynes NE: Correlation of c-erbB-2
gene amplification and protein expression in human breast carcinoma
with nodal status and nuclear grading. Cancer Res. 48:1238–1243.
1988.PubMed/NCBI
|
|
27
|
Okuyama Kishima M, de Oliveira CE,
Banin-Hirata BK, Losi-Guembarovski R, Brajão de Oliveira K,
Amarante MK and Watanabe MA: Immunohistochemical expression of
CXCR4 on breast cancer and its clinical significance. Anal Cell
Pathol (Amst). 2015:8910202015.
|
|
28
|
Kato M, Kitayama J, Kazama S and Nagawa H:
Expression pattern of CXC chemokine receptor-4 is correlated with
lymph node metastasis in human invasive ductal carcinoma. Breast
Cancer Res. 5:R144–R150. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salvucci O, Bouchard A, Baccarelli A,
Deschênes J, Sauter G, Simon R, Bianchi R and Basik M: The role of
CXCR4 receptor expression in breast cancer: A large tissue
microarray study. Breast Cancer Res Treat. 97:275–283. 2006.
View Article : Google Scholar
|
|
30
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang Z, Tang Y, Fang J, Zhou Z, Xing Z,
Guo Z, Guo X, Wang W, Jiao W, Xu Z, et al: Simvastatin inhibits
renal cancer cell growth and metastasis via AKT/mTOR, ERK and
JAK2/STAT3 pathway. PLoS One. 8:e628232013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu S, Lao XY, Sun TT, Ren LL, Kong X, Wang
JL, Wang YC, Du W, Yu YN, Weng YR, et al: Knockdown of ZFX inhibits
gastric cancer cell growth in vitro and in vivo via downregulating
the ERK-MAPK pathway. Cancer Lett. 337:293–300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ke Z, Lin H, Fan Z, Cai T-Q, Kaplan RA, Ma
C, Bower KA, Shi X and Luo J: MMP-2 mediates ethanol-induced
invasion of mammary epithelial cells over-expressing ErbB2. Int J
Cancer. 119:8–16. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui C, Wang P, Cui N, Song S, Liang H and
Ji A: Sulfated poly-saccharide isolated from the sea cucumber
Stichopus japonicas promotes the SDF-1α/CXCR4 axis-induced NSC
migration via the PI3K/Akt/FOXO3a, ERK/MAPK, and NF-κB signaling
pathways. Neurosci Lett. 616:57–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Merkhofer EC, Cogswell P and Baldwin AS:
Her2 activates NF-kappaB and induces invasion through the canonical
pathway involving IKKalpha. Oncogene. 29:1238–1248. 2010.
View Article : Google Scholar
|
|
36
|
Kukreja P, Abdel-Mageed AB, Mondal D, Liu
K and Agrawal KC: Up-regulation of CXCR4 expression in PC-3 cells
by stromal-derived factor-1alpha (CXCL12) increases endothelial
adhesion and transendothelial migration: Role of MEK/ERK signaling
pathway-dependent NF-kappaB activation. Cancer Res. 65:9891–9898.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bhat-Nakshatri P, Sweeney CJ and Nakshatri
H: Identification of signal transduction pathways involved in
constitutive NF-kappaB activation in breast cancer cells. Oncogene.
21:2066–2078. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Frasor J, Danes JM, Komm B, Chang KC,
Lyttle CR and Katzenellenbogen BS: Profiling of estrogen up- and
down-regulated gene expression in human breast cancer cells:
Insights into gene networks and pathways underlying estrogenic
control of proliferation and cell phenotype. Endocrinology.
144:4562–4574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sengupta S, Schiff R and Katzenellenbogen
BS: Post-transcriptional regulation of chemokine receptor CXCR4 by
estrogen in HER2 overexpressing, estrogen receptor-positive breast
cancer cells. Breast Cancer Res Treat. 117:243–251. 2009.
View Article : Google Scholar :
|
|
40
|
Fernandes J, Weinlich R, Castilho RO,
Amarante-Mendes GP and Gattass CR: Pomolic acid may overcome
multidrug resistance mediated by overexpression of anti-apoptotic
Bcl-2 proteins. Cancer Lett. 245:315–320. 2007. View Article : Google Scholar
|
|
41
|
Schlachterman A, Valle F, Wall KM, Azios
NG, Castillo L, Morell L, Washington AV, Cubano LA and
Dharmawardhane SF: Combined resveratrol, quercetin, and catechin
treatment reduces breast tumor growth in a nude mouse model. Transl
Oncol. 1:19–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
